<p>紐約，紐約 --（Newsfile Corp. -2025 年 7 月 30 日）- 如果您在 <strong>Centene Corporation</strong> 的投資中遭受損失，並希望瞭解根據聯邦證券法的潛在賠償，請點擊以下鏈接獲取更多信息：</p>
<p>https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=158915&amp;wire=5&amp;utm_campaign=29</p>
<p>或通過電子郵件聯繫 Joseph E. Levi 律師，郵箱為 jlevi@levikorsinsky.com，或撥打（212）363-7500 與我們經驗豐富的股東倡導團隊聯繫。</p>
<p><strong>訴訟：</strong> 針對 Centene Corporation 提起了一項集體訴訟，旨在為在 2024 年 12 月 12 日至 2025 年 6 月 30 日期間受到證券欺詐影響的股東追回損失。</p>
<p><strong>案件詳情：</strong> 根據投訴，被告向投資者提供了極為積極的聲明，同時傳播了實質性虛假和誤導性陳述和/或隱瞞了有關 Centene 的註冊和發病率的實質性不利事實。投資者在 2025 年 7 月 1 日開始質疑被告公開聲明的真實性，當時 Centene 發佈了一份新聞稿撤回 2025 年的指導意見。特別是，在對 2025 年健康保險市場的分析後，Centene 在 22 個州的整體市場增長，或佔公司市場會員的 72%，低於預期。公司表示，這一初步分析導致其之前發佈的指導意見減少至約 18 億美元，或調整後的稀釋每股收益為 2.75 美元。</p>
<p>在這一消息發佈後，Centene 的普通股大幅下跌，從 2025 年 7 月 1 日的收盤市場價格每股 56.65 美元跌至 2025 年 7 月 2 日的每股 33.78 美元，跌幅達 40.4%。</p>
<p><strong>接下來會怎樣？</strong> 如果您在相關時間段內在 Centene 股票中遭受損失——即使您仍持有股票——請訪問 https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=158915&amp;wire=5&amp;utm_campaign=29 瞭解您尋求賠償的權利。<strong>參與沒有費用或義務。</strong></p>
<p><strong>為什麼選擇 Levi &amp; Korsinsky：</strong> 在過去 20 年中，Levi &amp; Korsinsky LLP 已建立為一家全國知名的證券訴訟公司，為受害股東爭取了數億美元的賠償，並在高風險案件中贏得了良好的記錄。該公司在複雜證券訴訟方面擁有豐富的經驗，並擁有超過 70 名員工為客户服務。連續七年，Levi &amp; Korsinsky 在 ISS 證券集體訴訟服務的前 50 名報告中被評為美國頂尖證券訴訟公司之一。律師廣告。以往的結果並不保證類似的結果。</p>
<p><strong>聯繫方式：</strong></p>
<p>Levi &amp; Korsinsky, LLP</p>
<p>Joseph E. Levi, Esq.</p>
<p>Ed Korsinsky, Esq.</p>
<p>33 Whitehall Street, 17th Floor</p>
<p>紐約，NY 10004</p>
<p>jlevi@levikorsinsky.com</p>
<p>電話：（212）363-7500</p>
<p>傳真：（212）363-7171</p>
<p>https://zlk.com/</p>
<p>要查看本新聞稿的源版本，請訪問 https://www.newsfilecorp.com/release/260736</p>

康西哥

<p>針對 Centene Corporation（CNC）提起了一項集體訴訟，指控其在 2024 年 12 月 12 日至 2025 年 6 月 30 日期間對股東進行證券欺詐。投訴稱，Centene 誤導投資者關於其註冊和發病率的信息，導致公司撤回 2025 年指導後，股價從 56.65 美元大幅下跌至 33.78 美元。遭受損失的股東被鼓勵聯繫 Levi & Korsinsky LLP 以尋求潛在的賠償選項</p>

<p>New York, New York--(Newsfile Corp. - July 30, 2025) - If you suffered a loss on your <strong>Centene Corporation</strong> investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:</p>
<div class="lb-trans"><p>紐約，紐約 --（Newsfile Corp. -2025 年 7 月 30 日）- 如果您在 <strong>Centene Corporation</strong> 的投資中遭受損失，並希望瞭解根據聯邦證券法的潛在賠償，請點擊以下鏈接獲取更多信息：</p>
</div><p>https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=158915&amp;wire=5&amp;utm_campaign=29</p>
<div class="lb-trans"><p>https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=158915&amp;wire=5&amp;utm_campaign=29</p>
</div><p>or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.</p>
<div class="lb-trans"><p>或通過電子郵件聯繫 Joseph E. Levi 律師，郵箱為 jlevi@levikorsinsky.com，或撥打（212）363-7500 與我們經驗豐富的股東倡導團隊聯繫。</p>
</div><p><strong>THE LAWSUIT:</strong> A class action securities lawsuit was filed against Centene Corporation that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between December 12, 2024 and June 30, 2025.</p>
<div class="lb-trans"><p><strong>訴訟：</strong> 針對 Centene Corporation 提起了一項集體訴訟，旨在為在 2024 年 12 月 12 日至 2025 年 6 月 30 日期間受到證券欺詐影響的股東追回損失。</p>
</div><p><strong>CASE DETAILS:</strong> According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Centene's enrollment and morbidity rates. Investors began to question the veracity of defendants' public statements on July 1, 2025, when Centene issued a press release withdrawing 2025 guidance. Particularly, following an analysis of the 2025 Health Insurance Marketplace, Centene's overall market growth across 22 states, or 72% of the Company's marketplace membership, was lower than expected. In pertinent part, the Company stated that this preliminary analysis resulted in a reduction of its previously issued guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75.</p>
<div class="lb-trans"><p><strong>案件詳情：</strong> 根據投訴，被告向投資者提供了極為積極的聲明，同時傳播了實質性虛假和誤導性陳述和/或隱瞞了有關 Centene 的註冊和發病率的實質性不利事實。投資者在 2025 年 7 月 1 日開始質疑被告公開聲明的真實性，當時 Centene 發佈了一份新聞稿撤回 2025 年的指導意見。特別是，在對 2025 年健康保險市場的分析後，Centene 在 22 個州的整體市場增長，或佔公司市場會員的 72%，低於預期。公司表示，這一初步分析導致其之前發佈的指導意見減少至約 18 億美元，或調整後的稀釋每股收益為 2.75 美元。</p>
</div><p>Following this news, Centene's common stock declined dramatically, from a closing market price of $56.65 per share on July 1, 2025, Centene's stock price fell to $33.78 per share on July 2, 2025, a decline of 40.4%.</p>
<div class="lb-trans"><p>在這一消息發佈後，Centene 的普通股大幅下跌，從 2025 年 7 月 1 日的收盤市場價格每股 56.65 美元跌至 2025 年 7 月 2 日的每股 33.78 美元，跌幅達 40.4%。</p>
</div><p><strong>WHAT'S NEXT?</strong> If you suffered a loss in Centene stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=158915&amp;wire=5&amp;utm_campaign=29 to learn about your rights to seek a recovery. <strong>There is no cost or obligation to participate.</strong></p>
<div class="lb-trans"><p><strong>接下來會怎樣？</strong> 如果您在相關時間段內在 Centene 股票中遭受損失——即使您仍持有股票——請訪問 https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=158915&amp;wire=5&amp;utm_campaign=29 瞭解您尋求賠償的權利。<strong>參與沒有費用或義務。</strong></p>
</div><p><strong>WHY LEVI &amp; KORSINSKY:</strong> Over the past 20 years, Levi &amp; Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p><strong>為什麼選擇 Levi &amp; Korsinsky：</strong> 在過去 20 年中，Levi &amp; Korsinsky LLP 已建立為一家全國知名的證券訴訟公司，為受害股東爭取了數億美元的賠償，並在高風險案件中贏得了良好的記錄。該公司在複雜證券訴訟方面擁有豐富的經驗，並擁有超過 70 名員工為客户服務。連續七年，Levi &amp; Korsinsky 在 ISS 證券集體訴訟服務的前 50 名報告中被評為美國頂尖證券訴訟公司之一。律師廣告。以往的結果並不保證類似的結果。</p>
</div><p><strong>CONTACT:</strong></p>
<div class="lb-trans"><p><strong>聯繫方式：</strong></p>
</div><p>Levi &amp; Korsinsky, LLP</p>
<div class="lb-trans"><p>Levi &amp; Korsinsky, LLP</p>
</div><p>Joseph E. Levi, Esq.</p>
<div class="lb-trans"><p>Joseph E. Levi, Esq.</p>
</div><p>Ed Korsinsky, Esq.</p>
<div class="lb-trans"><p>Ed Korsinsky, Esq.</p>
</div><p>33 Whitehall Street, 17th Floor</p>
<div class="lb-trans"><p>33 Whitehall Street, 17th Floor</p>
</div><p>New York, NY 10004</p>
<div class="lb-trans"><p>紐約，NY 10004</p>
</div><p>jlevi@levikorsinsky.com</p>
<div class="lb-trans"><p>jlevi@levikorsinsky.com</p>
</div><p>Tel: (212) 363-7500</p>
<div class="lb-trans"><p>電話：（212）363-7500</p>
</div><p>Fax: (212) 363-7171</p>
<div class="lb-trans"><p>傳真：（212）363-7171</p>
</div><p>https://zlk.com/</p>
<div class="lb-trans"><p>https://zlk.com/</p>
</div><p>To view the source version of this press release, please visit https://www.newsfilecorp.com/release/260736</p>
<div class="lb-trans"><p>要查看本新聞稿的源版本，請訪問 https://www.newsfilecorp.com/release/260736</p>
</div>

針對 Centene Corporation（CNC）證券違規行為的集體訴訟已被提起 - 請立即聯繫 Levi & Korsinsky